Aldebaran Capital, LLC
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 10, 2025), Aldebaran Capital, LLC reported 33 stock positions worth $108.9 million. Its top holding was Berkshire Hathaway Class B (BRK.B) at 19.3% of the portfolio, followed by Microsoft (MSFT, 9.0%) and Occidental Petroleum (OXY, 7.3%). Compared with Q2 2025, it opened 2 new positions, sold out of 3, added to 2 and reduced 23. The biggest buy was Verizon Communications (VZ, shares +58%) and the biggest sale an exit from Essa Pharma (EPIX).
- Most Recent 13F
- Q2 2026
- Location
- CARMEL, IN
- CIK
- 0001448430
- Portfolio Value
- $108.9M (Q3 2025)
- SEC Filing
- 0001376474-25-000911 ↗ filed Nov 10, 2025
Holdings Value
Holdings 33 stocks · $108.9M
| BRK.B Berkshire Hathaway Inc. Class B | 19.35% | 41,901 | $21.1M | Reduce -0.6% |
| MSFT Microsoft Corp. | 9.04% | 18,999 | $9.8M | Reduce -0.6% |
| OXY Occidental Petroleum Corp. | 7.31% | 168,344 | $8.0M | Reduce -1.6% |
| BG Bunge Global SA | 7.26% | 97,297 | $7.9M | Reduce -0.8% |
| LLY Eli Lilly & Co. | 5.45% | 7,783 | $5.9M | No change |
| BAC Bank of America Corp. filed as BANK AMERICA CORP | 5.15% | 108,643 | $5.6M | Reduce -0.9% |
| IWS iShares Russell Mid-Cap Valu | 5.04% | 39,304 | $5.5M | Reduce -0.4% |
| SU Suncor Energy Inc. | 4.60% | 119,710 | $5.0M | Reduce -1.2% |
| CATO Cato Corp. Class A | 3.99% | 1,031,150 | $4.3M | Reduce -1.2% |
| CVX Chevron Corp. | 3.93% | 27,565 | $4.3M | Reduce -1.1% |
| JPM JPMorgan Chase & Co. | 3.33% | 11,482 | $3.6M | Reduce -3.6% |
| BCI Abrdn Bloomberg All Commodit filed as ABRDN ETFS | 2.95% | 149,075 | $3.2M | Reduce -0.7% |
| VZ Verizon Communications Inc. | 2.56% | 63,393 | $2.8M | Add +58.1% |
| AMLX Amylyx Pharmaceuticals Inc. | 2.55% | 204,474 | $2.8M | Reduce -6.1% |
| SIRI Sirius XM Holdings Inc. | 2.40% | 112,069 | $2.6M | Reduce -0.6% |
| ENB Enbridge Inc. | 1.92% | 41,400 | $2.1M | Reduce -0.9% |
| FCX Freeport-McMoran Inc. | 1.86% | 51,733 | $2.0M | Add +1.6% |
| ACRS Aclaris Therapeutics Inc. | 1.72% | 987,698 | $1.9M | Reduce -0.6% |
| CENX Century Aluminum Company | 1.61% | 59,565 | $1.7M | Reduce -2.6% |
| BRK.A Berkshire Hathaway Inc. Class A | 1.39% | 2 | $1.5M | No change |
| PATK Patrick Industries Inc. | 1.35% | 14,173 | $1.5M | Reduce -0.4% |
| RELL Richardson Elec Ltd. | 1.29% | 143,710 | $1.4M | Reduce -0.3% |
| PMVP PMV Pharmaceuticals Inc. | 0.65% | 504,128 | $706K | Reduce -2.1% |
| TECX Tectonic Therapeutic Inc. | 0.55% | 38,502 | $604K | Reduce -4.4% |
| TECK Teck Resources Ltd.-CLS B | 0.49% | 12,160 | $534K | Reduce -4.4% |
| AN2 THEREAPEUTICS INC | 0.46% | 392,754 | $499K | Reduce -2.5% |
| Duke Energy Corp New | 0.41% | 3,600 | $446K | No change |
| GE General Electric Company | 0.35% | 1,256 | $378K | No change |
| F Ford Motor Co. filed as FORD MTR CO | 0.31% | 28,150 | $337K | No change |
| MBIN Merchants Bancorp | 0.30% | 10,125 | $322K | No change |
| GEV GE Vernova Inc. | 0.19% | 332 | $204K | New |
| IMA Imagenebio Inc. | 0.15% | 19,562 | $159K | New |
| OKUR Onkure Therapeutics Inc. Class A | 0.11% | 43,997 | $121K | Reduce -0.4% |
Portfolio Sells Q2 2025 → Q3 2025
| EPIX Essa Pharma Inc. | Sold out | 0.00% | −0.97 |
| BRK.B Berkshire Hathaway Inc. Class B | Reduce -0.6% | 19.35% | −0.87 |
| BG Bunge Global SA | Reduce -0.8% | 7.26% | −0.51 |
| MSFT Microsoft Corp. | Reduce -0.6% | 9.04% | −0.34 |
| IKENA ONCOLOGY INC | Sold out | 0.00% | −0.32 |
| TECX Tectonic Therapeutic Inc. | Reduce -4.4% | 0.55% | −0.23 |
| PG The Procter & Gamble Co. | Sold out | 0.00% | −0.20 |
| SIRI Sirius XM Holdings Inc. | Reduce -0.6% | 2.40% | −0.16 |
| BCI Abrdn Bloomberg All Commodit | Reduce -0.7% | 2.95% | −0.13 |
| IWS iShares Russell Mid-Cap Valu | Reduce -0.4% | 5.04% | −0.10 |
| RELL Richardson Elec Ltd. | Reduce -0.3% | 1.29% | −0.08 |
| JPM JPMorgan Chase & Co. | Reduce -3.6% | 3.33% | −0.08 |
| TECK Teck Resources Ltd.-CLS B | Reduce -4.4% | 0.49% | −0.02 |
| CVX Chevron Corp. | Reduce -1.1% | 3.93% | −0.01 |
| OKUR Onkure Therapeutics Inc. Class A | Reduce -0.4% | 0.11% | +0.01 |
| BAC Bank of America Corp. | Reduce -0.9% | 5.15% | +0.03 |
| AN2 THEREAPEUTICS INC | Reduce -2.5% | 0.46% | +0.04 |
| PATK Patrick Industries Inc. | Reduce -0.4% | 1.35% | +0.05 |
| ENB Enbridge Inc. | Reduce -0.9% | 1.92% | +0.05 |
| PMVP PMV Pharmaceuticals Inc. | Reduce -2.1% | 0.65% | +0.11 |
| SU Suncor Energy Inc. | Reduce -1.2% | 4.60% | +0.12 |
| OXY Occidental Petroleum Corp. | Reduce -1.6% | 7.31% | +0.22 |
| ACRS Aclaris Therapeutics Inc. | Reduce -0.6% | 1.72% | +0.33 |
| CENX Century Aluminum Company | Reduce -2.6% | 1.61% | +0.52 |
| CATO Cato Corp. Class A | Reduce -1.2% | 3.99% | +1.09 |
| AMLX Amylyx Pharmaceuticals Inc. | Reduce -6.1% | 2.55% | +1.17 |
Portfolio Buys Q2 2025 → Q3 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 39 | $133.1M | BRK.B, LLY, MSFT, BG, IWS |
| Q1 2026 | 42 | $130.5M | BRK.B, OXY, BG, LLY, MSFT |
| Q4 2025 | 35 | $111.5M | BRK.B, LLY, MSFT, BG, OXY |
| Q3 2025 | 33 | $108.9M | BRK.B, MSFT, OXY, BG, LLY |
| Q2 2025 | 34 | $101.3M | BRK.B, MSFT, BG, OXY, LLY |
| Q1 2025 | 40 | $105.5M | BRK.B, OXY, BG, MSFT, LLY |
| Q4 2024 | 36 | $105.0M | BRK.B, MSFT, OXY, BG, BAC |
| Q3 2024 | 36 | $109.3M | BRK.B, MSFT, BG, OXY, LLY |
| Q2 2024 | 35 | $107.1M | BRK.B, OXY, BG, MSFT, LLY |
| Q1 2024 | 32 | $104.7M | BRK.B, OXY, BG, MSFT, LLY |